KRAZATI
Active substance: adagrasib
TABLET, COATED · ADAGRASIB 200 mg/1
United StatesActive
Marketing holder: Mirati Therapeutics, Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ADAGRASIB · 200 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-26ae-759e-8b71-579d26e6513e;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 80739-812
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 80739-812 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 80739-812 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 80739-812 · Verified 2026-10-09 · open in source